Pathophysiology of pyoderma gangrenosum (PG): an updated review
SF Braswell, TC Kostopoulos… - Journal of the American …, 2015 - Elsevier
Pyoderma gangrenosum is a challenging skin condition to identify and treat because of its
multifactorial pathogenesis. It is a rare cutaneous manifestation diagnosed clinically by …
multifactorial pathogenesis. It is a rare cutaneous manifestation diagnosed clinically by …
Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment
A Alavi, LE French, MD Davis, A Brassard… - American journal of …, 2017 - Springer
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical
clinical presentations. Its pathophysiology is complex and not fully explained. Recent …
clinical presentations. Its pathophysiology is complex and not fully explained. Recent …
Etiology and management of pyoderma gangrenosum: a comprehensive review
I Ahronowitz, J Harp, K Shinkai - American journal of clinical dermatology, 2012 - Springer
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful,
necrotic ulceration. It typically affects patients in the third to sixth decades of life, with almost …
necrotic ulceration. It typically affects patients in the third to sixth decades of life, with almost …
[HTML][HTML] Recent advances in managing and understanding pyoderma gangrenosum
J Fletcher, R Alhusayen, A Alavi - F1000Research, 2019 - ncbi.nlm.nih.gov
Pyoderma Gangrenosum (PG) is a rare neutrophilic dermatosis with multiple different
clinical presentations and associated comorbidities. PG has historically been a challenging …
clinical presentations and associated comorbidities. PG has historically been a challenging …
Pyoderma gangrenosum: a review of pathogenesis and treatment
C Ahn, D Negus, W Huang - Expert review of clinical immunology, 2018 - Taylor & Francis
Introduction: Pyoderma gangrenosum (PG) is a complex neutrophilic dermatosis that can
occur as an idiopathic disease, in association with systemic conditions such as inflammatory …
occur as an idiopathic disease, in association with systemic conditions such as inflammatory …
Pyoderma gangrenosum: challenges and solutions
A Gameiro, N Pereira, JC Cardoso… - Clinical, cosmetic and …, 2015 - Taylor & Francis
Pyoderma gangrenosum (PG) is a rare disease, but commonly related to important
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …
Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments
CA Maronese, MA Pimentel, MM Li… - American Journal of …, 2022 - Springer
Pyoderma gangrenosum is a rare inflammatory skin disease classified within the group of
neutrophilic dermatoses and clinically characterized by painful, rapidly evolving cutaneous …
neutrophilic dermatoses and clinically characterized by painful, rapidly evolving cutaneous …
Pyoderma gangrenosum: a review and update on new therapies
J Miller, BA Yentzer, A Clark, JL Jorizzo… - Journal of the American …, 2010 - Elsevier
Pyoderma gangrenosum is a rare and often painful skin disease that can be unpredictable
in its response to treatment. There is currently no gold standard of treatment or published …
in its response to treatment. There is currently no gold standard of treatment or published …
Pyoderma gangrenosum
E Maverakis, AV Marzano, ST Le, JP Callen… - Nature Reviews …, 2020 - nature.com
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly
developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema …
developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema …
Pyoderma gangrenosum: a review
A Neil Crowson, M C. Mihm Jr… - Journal of cutaneous …, 2003 - Wiley Online Library
Since its first description in 1930, the pathogenesis of pyoderma gangrenosum (PG) has
remained obscure even as an ever‐widening array of systemic diseases has been …
remained obscure even as an ever‐widening array of systemic diseases has been …